# Improving White Blood Cell Collection From Healthy Donors

> **NCT01553214** · PHASE4 · RECRUITING · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 1000 (estimated)

## Conditions studied

- Allogeneic Granulocyte Donation

## Interventions

- **DRUG:** Filgrastim
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01553214
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2012-12-31
- **Primary completion:** 2032-01-01
- **Final completion:** 2032-01-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01553214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01553214, "Improving White Blood Cell Collection From Healthy Donors". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01553214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*